Hearing News Watch

Featured image for “U.S. Department of Labor Seeks Input on Future Standards for Occupational Hearing Loss Testing”
Jun. 26, 2026

U.S. Department of Labor Seeks Input on Future Standards for Occupational Hearing Loss Testing

HHTM
WASHINGTON, D.C. — The U.S. Department of Labor’s Office of Workers’ Compensation Programs (OWCP) is seeking public input on whether current methods used to evaluate occupational hearing loss remain the most reliable and appropriate, opening the door to a broader discussion about the role of objective hearing tests alongside traditional audiograms. In a Request for Information (RFI), the agency is
Featured image for “Study Identifies New Genetic Clues to the Origins of Ménière’s Disease”
Jun. 26, 2026

Study Identifies New Genetic Clues to the Origins of Ménière’s Disease

HHTM
Researchers at the University of Pennsylvania have identified genetic evidence suggesting that Ménière’s disease may be linked, in part, to early developmental pathways in the inner ear, offering a new framework for understanding a disorder that has long been difficult to explain biologically. The findings, published in The American Journal of Human Genetics, come from what the researchers describe as
Featured image for “Sanofi Takes Equity Stake in Cilcare as Hearing Therapeutics Partnership Expands”
Jun. 23, 2026

Sanofi Takes Equity Stake in Cilcare as Hearing Therapeutics Partnership Expands

HHTM
MONTPELLIER, FRANCE & BOSTON, MASS. — Cilcare announced an update to its licensing agreement with Sanofi covering its two lead programs, CIL001 and CIL003. The revised agreement includes improved royalty terms for Cilcare and will make Sanofi a minority shareholder in the company. Cilcare said the updated agreement reflects the progress and value of its lead programs and represents another
Featured image for “Amplifon Secures €1.35 Billion Loan to Support GN Hearing Acquisition”
Jun. 23, 2026

Amplifon Secures €1.35 Billion Loan to Support GN Hearing Acquisition

HHTM
MILAN, ITALY — Amplifon announced that it has secured a €1.35 billion senior loan to support the financing of its proposed acquisition of GN Hearing. The financing marks the latest step in the proposed transaction, which was first announced in March and would bring GN Hearing’s technology, manufacturing, and audiological product portfolio together with Amplifon’s global hearing care retail network.
Featured image for “WSA CFO Marianne Wiinholt to Step Down in August 2026”
Jun. 23, 2026

WSA CFO Marianne Wiinholt to Step Down in August 2026

HHTM
LYNGE, DENMARK — WSA announced that Chief Financial Officer Marianne Wiinholt will step down from her role on August 31, 2026, after four years as CFO and a member of the company’s Executive Committee. According to the company, Wiinholt made the decision to leave at her own request to pursue a portfolio of board and advisory roles. She will remain
Featured image for “New Book Examines Growth Opportunities in Recreational and Industrial Audiology”
Jun. 22, 2026

New Book Examines Growth Opportunities in Recreational and Industrial Audiology

HHTM
A new book by veteran audiologist Garry G. Gordon, MS, examines how hearing healthcare professionals may expand their services beyond traditional clinical practice through industrial hearing conservation, recreational hearing protection, tinnitus management, and emerging hearing technologies. Recreational & Industrial Audiology: The Next Profitable Frontier outlines potential growth areas as the hearing healthcare landscape continues to evolve. Drawing on decades of
Featured image for “Starkey Named 2026 Star Tribune Top Workplace for Fifth Consecutive Year”
Jun. 20, 2026

Starkey Named 2026 Star Tribune Top Workplace for Fifth Consecutive Year

HHTM
EDEN PRAIRIE, MINNESOTA — Starkey has been named a 2026 Star Tribune Top Workplace, marking the fifth consecutive year the company has earned the distinction. The award is based entirely on employee feedback gathered through a confidential engagement survey that measures workplace culture, leadership, communication, and employee experience. The recognition reflects Starkey’s ongoing commitment to fostering a workplace where employees are
Featured image for “Your Experience Matters: Hearing Care Professionals Invited to Participate in New Survey”
Jun. 14, 2026

Your Experience Matters: Hearing Care Professionals Invited to Participate in New Survey

HHTM
Hearing healthcare is evolving rapidly. While advances in technology continue to transform the profession, there is also a growing emphasis on patient-centered care that extends beyond the audiogram to communication, participation, and quality of life. To better understand where the profession stands today, HHTM is inviting hearing care professionals to participate in the Current State of Hearing Care Survey. The
Featured image for “Acousia Reports Promising First-in-Patient Phase 2a Results for ACOU085 in Cisplatin-Induced Ototoxicity”
Jun. 12, 2026

Acousia Reports Promising First-in-Patient Phase 2a Results for ACOU085 in Cisplatin-Induced Ototoxicity

HHTM
TÜBINGEN, GERMANY — Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, today announced positive top-line efficacy results from its completed Phase 2a PROHEAR study. ACOU085 (INN: Bimokalner) is a proprietary small-molecule therapy that has demonstrated efficacy across multiple preclinical models of hearing loss, including drug-induced ototoxicity. The exploratory, placebo-controlled, split-body Phase 2a
Featured image for “Management of the Tinnitus and Hyperacusis Patient – 33rd Annual International Conference”
Jun. 11, 2026

Management of the Tinnitus and Hyperacusis Patient – 33rd Annual International Conference

HHTM
IOWA CITY, IA — The University of Iowa has announced the upcoming 33rd Annual Management of the Tinnitus & Hyperacusis Patient International Conference, scheduled for August 13–14, 2026. The event will be offered in a hybrid format, with in-person sessions held at the Wendell Johnson Speech & Hearing Center, as well as a remote attendance option. The long-running conference is